Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray W Huff

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Annual Review of Pharmacology and Toxicology|August 31, 2016
PCSK9: Regulation and Target for Drug Development for DyslipidemiaAmy C Burke, Jacqueline S Dron, Robert A Hegele, et al.
Biochimica Et Biophysica Acta|January 24, 2006
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJohn R Burnett, Dawn E Telford, P Hugh R Barrett, et al.
Journal of Lipid Research|September 18, 2002
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl estersNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Clinical Biochemistry|June 1, 2005
Quality assessment of microarray experimentsDavid E Carter, John F Robinson, Emma M Allister, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
From cells to organism: impact of dyslipidemia on inwardly rectifying K<sup>+</sup> channels and cerebral vascular functionPaulina M Kowalewska, Maria Sancho, Sergio Fabris, et al.
The Biochemical Journal|May 29, 2002
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanismsNica M Borradaile, Linda E de Dreu, Lisa J Wilcox, et al.
Clinical Biochemistry|May 2, 2002
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipaseKhalid Al-Shali, Jian Wang, Fraser Fellows, et al.
Canadian Family Physician Medecin De Famille Canadien|May 14, 2010
Canadian global village reality: anthropometric surrogate cutoffs and metabolic abnormalities among Canadians of East Asian, South Asian, and European descentMeizi He, E T S Li, Stewart Harris, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2003
Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophyRobert A Hegele, Maria E Kraw, Matthew R Ban, et al.
Biochemistry|February 5, 2003
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulationNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Annual Review of Pharmacology and Toxicology|August 31, 2016
PCSK9: Regulation and Target for Drug Development for DyslipidemiaAmy C Burke, Jacqueline S Dron, Robert A Hegele, et al.
Biochimica Et Biophysica Acta|January 24, 2006
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJohn R Burnett, Dawn E Telford, P Hugh R Barrett, et al.
Journal of Lipid Research|September 18, 2002
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl estersNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Clinical Biochemistry|June 1, 2005
Quality assessment of microarray experimentsDavid E Carter, John F Robinson, Emma M Allister, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
From cells to organism: impact of dyslipidemia on inwardly rectifying K<sup>+</sup> channels and cerebral vascular functionPaulina M Kowalewska, Maria Sancho, Sergio Fabris, et al.
The Biochemical Journal|May 29, 2002
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanismsNica M Borradaile, Linda E de Dreu, Lisa J Wilcox, et al.
Clinical Biochemistry|May 2, 2002
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipaseKhalid Al-Shali, Jian Wang, Fraser Fellows, et al.
Canadian Family Physician Medecin De Famille Canadien|May 14, 2010
Canadian global village reality: anthropometric surrogate cutoffs and metabolic abnormalities among Canadians of East Asian, South Asian, and European descentMeizi He, E T S Li, Stewart Harris, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2003
Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophyRobert A Hegele, Maria E Kraw, Matthew R Ban, et al.
Biochemistry|February 5, 2003
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulationNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Pageof 8